Overview

Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients

Status:
Withdrawn

Trial end date:
2011-01-01

Target enrollment:
0

Participant gender:
All

Summary

The primary objective of this study is to measure efficacy of our new protocol by monitoring the results of our routine respiratory cultures at the end of the new standard treatment, and during routine visits for 1 year from initiation of therapy for Staphylococcus aureus. The secondary objective will include determining the clinical course (pulmonary exacerbations, antibiotic use, hospitalizations, pulmonary function tests) of patients who underwent the protocol.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

State University of New York - Upstate Medical University

Criteria

Inclusion Criteria:

Eligible participants will include all patients with CF who test positive for SA from
respiratory tract culture (throat, nares or expectorated sputum) and are 2-23 months of age
at protocol presentation.

Exclusion Criteria:

Patients co-infected with other bacteria (e.g. Pseudomonas) or documented to have an
allergy or resistance to any of the intervention substances will be excluded.